Skip to main content

Table 3 Multivariate analysis with Cox’s proportional hazards model for prognostic factors in breast cancer patients

From: Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer

 

Overall survival

Disease-free survival

HR

95% CI

P-value*

HR

95% CI

P-value*

Tumor size (≤2 or >2 cm)

2.873

0.85-9.73

0.090

3.153

0.93-10.71

0.066

Lymph node status (negative or positive)

1.088

0.45-2.62

0.851

1.988

0.83-4.75

0.122

Stage (I, II or III)

4.454

2.46-8.06

0.000

3.577

1.926-6.643

0.000

Stromal MMP-1 expression (negative or positive)

0.528

0.29-0.98

0.042

-

-

-

Tumor TIMP-3 expression (negative or positive)

-

-

-

3.003

0.71-12.63

0.133

  1. * Multivariate analysis was carried out on all variables that were found to be significant in univariate analysis.
  2. HR, hazard rate; CI, confidence interval; -, not significant in univariate analysis.